Randomized Crossover Study to Examine the Necessity of an Injection-to-Meal Interval in Patients With Type 2 Diabetes and Human Insulin
Authors:
Open Access
- 12 June 2013
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 36 (7) , 1865-1869
Abstract
OBJECTIVE Patients with diabetes and insulin therapy with human insulin were usually instructed to use an interval of 20–30 min between the injection and meal. We examined the necessity of the injection-to-meal interval (IMI) in patients with type 2 diabetes mellitus (T2DM) and flexible insulin therapy with human insulin. RESEARCH DESIGN AND METHODS In this randomized, open crossover trial, 100 patients with T2DM (47% men, mean age = 66.7 years) were randomized to the IMI first group (phase 1, IMI 20 min; phase 2, no IMI) or IMI last group (phase 1, no IMI; phase 2, IMI 20 min). The main outcome measures were HbA1c, blood glucose profile, incidence of hypoglycemia, quality of life, treatment satisfaction, and patient preference. RESULTS Forty-nine patients were randomized to the IMI first group and 51 patients to the IMI last group. Omitting the IMI only slightly increases HbA1c (average intraindividual difference = 0.08% [95% CI 0.01–0.15]). Since the difference is not clinically relevant, a therapy without IMI is noninferior to its application (P < 0.001). In the secondary outcomes, the incidence of mild hypoglycemia also did not differ between no IMI and IMI significantly (mean of differences = −0.10, P = 0.493). No difference in the blood glucose profile of both groups was found. Treatment satisfaction increased markedly, by 8.08, if IMI was omitted (P < 0.001). The total score of the quality of life measure did not show differences between applying an IMI or not. Insulin therapy without IMI was preferred by 86.5% of patients (P < 0.001). CONCLUSIONS An IMI for patients with T2DM and preprandial insulin therapy is not necessary.Keywords
This publication has 20 references indexed in Scilit:
- Treatment Satisfaction and Quality of Life With Insulin Glargine Plus Insulin Lispro Compared With NPH Insulin Plus Unmodified Human Insulin in Individuals With Type 1 DiabetesDiabetes Care, 2008
- Sind "Designer"-Insuline die "besseren" Insuline?Wiener klinische Wochenschrift, 2005
- Interval between insulin injection and meal in relation to glycated haemoglobinPractical Diabetes International, 2001
- A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapyDiabetic Medicine, 2000
- Immunological and Metabolic Responses of Patients with History of Antibody-Induced Beef Insulin Resistance to Treatment With Beef, Pork, Human, and Sulfated Beef InsulinDiabetes Care, 1992
- Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.BMJ, 1985
- Roles of site and timing of the morning insulin injection in type 1 diabetesThe Journal of Pediatrics, 1983
- Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes MellitusDiabetes Care, 1983
- Factors Influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin MixturesDiabetes Care, 1981
- Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic childrenBMJ, 1980